✦ LIBER ✦

Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients

✍ Scribed by G Sterkers; V Baudouin; H Ansart-Pirenne; A Maisin; P Niaudet; P Cochat; C Loirat

Book ID: 117229933
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 120 KB
Volume: 32
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(00)01868-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoprophylaxis with basiliximab, a ch

Immunoprophylaxis with basiliximab, a chimeric anti–interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients

✍ Yvon Calmus; Johannes R. Scheele; Ignacio Gonzalez-Pinto; Eduardo J. Jaurrieta; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients

✍ T. Haba; K. Uchida; A. Katayama; Y. Tominaga; T. Sato; I. Watanabe; H. Inagaki; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Ten year follow-up of recipients of a ki

Ten year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor

✍ M Wabbijn; A Balk; R van Domburg; P Vantrimpont; I van Riemsdijk; C Baan; W Weim 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Limited benefits of induction with monoc

Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney–pancreas transplantation

✍ A Lo; R.J Stratta; R.R Alloway; M.F Egidi; M.H Shokouh-Amiri; H.P Grewal; A.O Ga 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been